As of 2025-05-20, the Intrinsic Value of Apollo Medical Holdings Inc (AMEH) is 54.16 USD. This AMEH valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 40.82 USD, the upside of Apollo Medical Holdings Inc is 32.70%.
The range of the Intrinsic Value is 41.07 - 81.81 USD
Based on its market price of 40.82 USD and our intrinsic valuation, Apollo Medical Holdings Inc (AMEH) is undervalued by 32.70%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 41.07 - 81.81 | 54.16 | 32.7% |
DCF (Growth 10y) | 59.19 - 115.17 | 77.30 | 89.4% |
DCF (EBITDA 5y) | 48.49 - 80.01 | 64.24 | 57.4% |
DCF (EBITDA 10y) | 66.66 - 111.57 | 87.97 | 115.5% |
Fair Value | 23.86 - 23.86 | 23.86 | -41.54% |
P/E | 14.09 - 39.31 | 26.68 | -34.6% |
EV/EBITDA | 24.89 - 42.53 | 34.12 | -16.4% |
EPV | 21.19 - 28.01 | 24.60 | -39.7% |
DDM - Stable | 7.80 - 20.08 | 13.94 | -65.8% |
DDM - Multi | 32.37 - 64.45 | 43.06 | 5.5% |
Market Cap (mil) | 1,958.54 |
Beta | 1.21 |
Outstanding shares (mil) | 47.98 |
Enterprise Value (mil) | 1,895.74 |
Market risk premium | 4.60% |
Cost of Equity | 8.42% |
Cost of Debt | 7.52% |
WACC | 8.10% |